Literature DB >> 6306404

Activity of human serum lipoproteins on the infectivity of rhabdoviruses.

L Seganti, M Grassi, P Mastromarino, A Panà, F Superti, N Orsi.   

Abstract

The inhibiting activity of various human serum lipoprotein classes and their lipid components on the infectivity of rhabdoviruses has been studied. The research has been carried out according to different experimental procedures on both the vesicular stomatitis virus (Indiana strain), and the fixed rabies virus (CVS strain). The results obtained have shown an inhibition of the infectivity of VSV and CVS, mainly linked to the very low and low density lipoprotein classes. It has also been demonstrated that the inhibitors act directly on viruses causing a decrease in their attachment to host cells.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6306404

Source DB:  PubMed          Journal:  Microbiologica        ISSN： 0391-5352


  7 in total

1.  Identification of lipid components of human serum lipoproteins involved in the inhibition of Sindbis virus infectivity, hemagglutination, and hemolysis.

Authors:  P Mastromarino; C Conti; S Rieti; N Orsi
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

2.  VSV binding to lipids from different cell lines. Brief report.

Authors:  D Viti; L Sinibaldi; F Superti; L Melucci; N Orsi
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

3.  Role for monokines in the metabolic effects of endotoxin. Interferon-gamma restores responsiveness of C3H/HeJ mice in vivo.

Authors:  S Adi; A S Pollock; J K Shigenaga; A H Moser; K R Feingold; C Grunfeld
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

4.  Role of phospholipids in rhabdovirus attachment to CER cells. Brief report.

Authors:  F Superti; L Seganti; H Tsiang; N Orsi
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

5.  Endotoxin and cytokines increase hepatic messenger RNA levels and serum concentrations of apolipoprotein J (clusterin) in Syrian hamsters.

Authors:  I Hardardóttir; S T Kunitake; A H Moser; W T Doerrler; J H Rapp; C Grünfeld; K R Feingold
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

6.  Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death.

Authors:  H W Harris; C Grunfeld; K R Feingold; T E Read; J P Kane; A L Jones; E B Eichbaum; G F Bland; J H Rapp
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

7.  Role for circulating lipoproteins in protection from endotoxin toxicity.

Authors:  K R Feingold; J L Funk; A H Moser; J K Shigenaga; J H Rapp; C Grunfeld
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.